CIK 0000313143 · Large accelerated filer
HAEMONETICS CORP
Sign in to watch- Ticker
- HAE
- Exchange
- NYSE
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Apr 3
- Incorporated
- MA
- Entity type
- operating
- EIN
- 042882273
- Phone
- 7818487100
- Business address
- 125 SUMMER STREET, BOSTON, MA, 02110
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $101,148
- in 1 filing
Net −$101,148. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-05-18 | Burke William P. Mr. EVP, Chief Financial Officer | Grant or award | +3,144 | 13,334 | ||
| 2020-05-18 | Burke William P. Mr. EVP, Chief Financial Officer | Grant or award · Non-qualified Stock Option (Right to Buy) | +10,639 | 10,639 | ||
| 2020-05-15 | Simon, Christopher President & CEO | Sale | −1,008 | $100.44 | $101K | 303,757 |
| 2020-05-15 | Goldstein Dan VP, Corporate Controller | Sale | −42 | $100.44 | $4K | 1,810 |
| 2020-05-15 | Llorens Josep SVP, Global Manufacturing | Sale | −107 | $100.44 | $11K | 2,663 |
| 2020-05-15 | Scanlan Jacqueline SVP, Global Human Resources | Sale | −110 | $100.44 | $11K | 4,466 |
| 2020-05-15 | Basil Michelle L EVP and General Counsel | Sale | −203 | $100.44 | $20K | 14,161 |
| 2020-05-15 | Burke William P. Mr. EVP, Chief Financial Officer | Sale | −221 | $100.44 | $22K | 10,190 |
| 2020-04-16 | COYLE MICHAEL J Director | Grant or award | +478 | 478 | ||
| 2020-04-15 | Lingamneni Anila EVP, Chief Technology Officer | Grant or award | +2,181 | 2,181 | ||
| 2020-04-15 | Lingamneni Anila EVP, Chief Technology Officer | Grant or award · Non-qualified Stock Option (Right to Buy) | +7,509 | 7,509 | ||
| 2020-04-09 | KROLL MARK W Director | Option exercise | +6,573 | $45.45 | $299K | 29,320 |
| 2020-04-09 | KROLL MARK W Director | Sale | −6,573 | $102.00 | $670K | 22,747 |
| 2020-04-09 | KROLL MARK W Director | Sale | −4,329 | $102.00 | $442K | 18,418 |
| 2020-04-09 | KROLL MARK W Director | Option exercise · Non-qualified Stock Option (Right to Buy) | −6,573 | 0 | ||
| 2020-04-08 | Goldstein Dan VP, Corporate Controller | Sale | −399 | $97.12 | $39K | 1,852 |
| 2020-04-07 | Goldstein Dan VP, Corporate Controller | Sale | −201 | $103.91 | $21K | 2,251 |
| 2020-04-06 | Goldstein Dan VP, Corporate Controller | Option exercise | +2,607 | $34.42 | $90K | 5,059 |
| 2020-04-06 | Goldstein Dan VP, Corporate Controller | Sale | −2,607 | $101.62 | $265K | 2,452 |
| 2020-04-06 | Goldstein Dan VP, Corporate Controller | Option exercise · Non-qualified Stock Option (Right to Buy) | −2,607 | 0 |
Page 24 of 29 · 570 trades